B2DB — Who said what, where, and when

Matthew Kellinger

Co-Founder and SVP of Product Strategy, Element Biosciences

Matthew Kellinger is listed as Co-Founder and SVP of Product Strategy, Element Biosciences. Matthew is scheduled to speak at SLAS 2027 International Conference & Exhibition on 3 February 2027.

Compiled from published conference agendas; not yet confirmed by Matthew. Is this you? Claim this profile.

About

Matthew co-founded Element Biosciences and serves as the Senior Vice President of Product Strategy. He previously served as Vice President of Biochemistry. With an expertise in enzymatic reactions and the kinetics of sequencing, he leads innovation in chemistry to drive improvements in high-throughput sequencing and biology solutions. Matthew earned his PhD at the University of Texas in Austin where he focused on mechanisms of Reverse Transcriptase and HIV drug resistance. He continued his research at UC San Diego where he studied RNA transcription fidelity. As a Staff Scientist at Illumina, Matthew focused on protein engineering to support and develop the future of genome sequencing. Collaborating with his colleagues, Molly He and Michael Previte, he engineered enzymes for sequencing applications to drive greater efficiency and accuracy across all aspects of sequencing technology.

Upcoming

SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027